NEXIMMUNE, INC.
CIK 0001538210
Revenue (TTM)
$0
Q2 Aug 2024
Net Income (TTM)
−$22.82M
+48.3% YoY
Q2 Aug 2024
EPS Diluted (TTM)
−$20.80
+52.5% YoY
Q2 Aug 2024
Gross Margin
—
Q2 Aug 2024
Operating Margin
—
Q2 Aug 2024
Net Margin
—
Q2 Aug 2024
Free Cash Flow (TTM)
−$43.3M
Q2 Aug 2024
Cash
$2.42M
Q2 Aug 2024
Total Debt
$0
Q2 Aug 2024
Shares Outstanding
1.39M sh
Q2 Aug 2024
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.